Andreas Henning

792 total citations
9 papers, 619 citations indexed

About

Andreas Henning is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, Andreas Henning has authored 9 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Dermatology. Recurrent topics in Andreas Henning's work include Inhalation and Respiratory Drug Delivery (5 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Andreas Henning is often cited by papers focused on Inhalation and Respiratory Drug Delivery (5 papers), Advancements in Transdermal Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Andreas Henning collaborates with scholars based in Germany, United States and Czechia. Andreas Henning's co-authors include Claus‐Michael Lehr, Craig S. Schneider, Laura M. Ensign, Justin Hanes, Marc Schneider, Dirk Neumann, Ulrich F. Schaefer, Brian W. Simons, Jane Chisholm and Pichet Adstamongkonkul and has published in prestigious journals such as Science Advances, European Journal of Pharmaceutics and Biopharmaceutics and Molecular Pharmaceutics.

In The Last Decade

Andreas Henning

9 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Henning Germany 9 347 244 134 74 69 9 619
Sharif Abdelghany Jordan 10 327 0.9× 132 0.5× 84 0.6× 138 1.9× 109 1.6× 16 545
Esmaeil Moazeni Iran 10 281 0.8× 167 0.7× 95 0.7× 16 0.2× 84 1.2× 15 485
Piush Khare India 13 235 0.7× 60 0.2× 196 1.5× 50 0.7× 115 1.7× 23 670
Željka Pavelić Croatia 9 371 1.1× 40 0.2× 156 1.2× 36 0.5× 111 1.6× 10 604
Catherine Lombry Belgium 8 335 1.0× 382 1.6× 80 0.6× 31 0.4× 30 0.4× 9 632
Duy‐Khiet Ho Germany 12 126 0.4× 101 0.4× 121 0.9× 16 0.2× 89 1.3× 20 408
Ashlee D. Brunaugh United States 12 166 0.5× 203 0.8× 113 0.8× 15 0.2× 28 0.4× 16 420
Mohamed Ehab Ali Germany 10 158 0.5× 124 0.5× 95 0.7× 11 0.1× 85 1.2× 11 436
Riham M. El‐Moslemany Egypt 15 211 0.6× 32 0.1× 146 1.1× 45 0.6× 84 1.2× 27 616
Menna M. Abdellatif Egypt 13 411 1.2× 30 0.1× 128 1.0× 83 1.1× 80 1.2× 30 664

Countries citing papers authored by Andreas Henning

Since Specialization
Citations

This map shows the geographic impact of Andreas Henning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Henning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Henning more than expected).

Fields of papers citing papers by Andreas Henning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Henning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Henning. The network helps show where Andreas Henning may publish in the future.

Co-authorship network of co-authors of Andreas Henning

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Henning. A scholar is included among the top collaborators of Andreas Henning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Henning. Andreas Henning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schneider, Craig S., Qingguo Xu, Nicholas J. Boylan, et al.. (2017). Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. Science Advances. 3(4). e1601556–e1601556. 237 indexed citations
2.
Ensign, Laura M., Andreas Henning, Craig S. Schneider, et al.. (2013). Ex Vivo Characterization of Particle Transport in Mucus Secretions Coating Freshly Excised Mucosal Tissues. Molecular Pharmaceutics. 10(6). 2176–2182. 87 indexed citations
3.
Henning, Andreas, Marc Schneider, Noha Nafee, et al.. (2010). Influence of Particle Size and Material Properties on Mucociliary Clearance from the Airways. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(4). 233–241. 75 indexed citations
4.
Bur, Michael, Andreas Henning, Stephanie Hein, Marc Schneider, & Claus‐Michael Lehr. (2009). Inhalative nanomedicine—Opportunities and challenges. Inhalation Toxicology. 21(sup1). 137–143. 43 indexed citations
5.
Henning, Andreas, Stephanie Hein, Marc Schneider, Michael Bur, & Claus‐Michael Lehr. (2009). Pulmonary Drug Delivery: Medicines for Inhalation. Handbook of experimental pharmacology. 171–192. 24 indexed citations
6.
Henning, Andreas, Ulrich F. Schaefer, & Dirk Neumann. (2008). Potential pitfalls in skin permeation experiments: Influence of experimental factors and subsequent data evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 72(2). 324–331. 32 indexed citations
7.
Henning, Andreas, et al.. (2008). Influence of Human Skin Specimens Consisting of Different Skin Layers on the Result of in vitro Permeation Experiments. Skin Pharmacology and Physiology. 21(2). 81–88. 22 indexed citations
8.
Henning, Andreas, et al.. (2008). Embryonic Chicken Trachea as a New In Vitro Model for the Investigation of Mucociliary Particle Clearance in the Airways. AAPS PharmSciTech. 9(2). 521–527. 19 indexed citations
9.
Hansen, Steffi, Andreas Henning, Arne Naegel, et al.. (2007). In-silico model of skin penetration based on experimentally determined input parameters. Part I: Experimental determination of partition and diffusion coefficients. European Journal of Pharmaceutics and Biopharmaceutics. 68(2). 352–367. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharif Abdelghany Breakdown of academic impact, for papers by Esmaeil Moazeni Breakdown of academic impact, for papers by Piush Khare Breakdown of academic impact, for papers by Željka Pavelić Breakdown of academic impact, for papers by Catherine Lombry Breakdown of academic impact, for papers by Duy‐Khiet Ho Breakdown of academic impact, for papers by Ashlee D. Brunaugh Breakdown of academic impact, for papers by Mohamed Ehab Ali Breakdown of academic impact, for papers by Riham M. El‐Moslemany Breakdown of academic impact, for papers by Menna M. Abdellatif
Rankless by CCL
2026